1 |
Shi B, Zhang Y, Huang B, Lin H, Zhou Q, Wang Y, Cai Z, Liu M. The System Profile of Renal Drug Transporters in Tubulointerstitial Fibrosis Model and Consequent Effect on Pharmacokinetics. Molecules 2022;27:704. [PMID: 35163972 DOI: 10.3390/molecules27030704] [Reference Citation Analysis]
|
2 |
Cherngwelling R, Pengrattanachot N, Swe MT, Thongnak L, Promsan S, Phengpol N, Sutthasupha P, Lungkaphin A. Agomelatine protects against obesity-induced renal injury by inhibiting endoplasmic reticulum stress/apoptosis pathway in rats. Toxicol Appl Pharmacol 2021;425:115601. [PMID: 34081941 DOI: 10.1016/j.taap.2021.115601] [Reference Citation Analysis]
|
3 |
Cabral LMP, Almeida FG, Grelle GMRS, Vieyra A, Caruso-neves C, Einicker-lamas M. Ceramide-1-Phosphate as a Potential Regulator of the Second Sodium Pump from Kidney Proximal Tubules by Triggering Distinct Protein Kinase Pathways in a Hierarchic Way. CIMB 2022;44:998-1011. [DOI: 10.3390/cimb44030066] [Reference Citation Analysis]
|
4 |
Shen QQ, Wang JJ, Roy D, Sun LX, Jiang ZZ, Zhang LY, Huang X. Organic anion transporter 1 and 3 contribute to traditional Chinese medicine-induced nephrotoxicity. Chin J Nat Med 2020;18:196-205. [PMID: 32245589 DOI: 10.1016/S1875-5364(20)30021-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
5 |
Torres AM, Dnyanmote AV, Granados JC, Nigam SK. Renal and non-renal response of ABC and SLC transporters in chronic kidney disease. Expert Opin Drug Metab Toxicol 2021;17:515-42. [PMID: 33749483 DOI: 10.1080/17425255.2021.1899159] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|